# eCaseLinkMe — Electronic Clinical Trial App

> Clinical trial management app for online and offline use. (iPhone/iPad app by Signant Health Oy.)

- Source: https://appshunter.io/ios/app/ecaselinkme/id1524781385 (this page in markdown: same URL + `.md`)
- Developer: [Signant Health Oy](https://appshunter.io/developer/885378600)
- Category: Health & Fitness
- Price: Free
- Rating: 1.00/5 from 1 App Store ratings · 1 written reviews indexed
- Age rating: 4+
- Requires: iOS 9.0 · 56 MB
- Released: 2020-10-13
- Data updated: 2026-06-10
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/ecaselinkme/id1524781385/reviews.md

## What is eCaseLinkMe?

eCaseLinkMe is a Free clinical trial app for iPhone and other smart phones. App uses your internet connection and local storage for Online and Offline usage

## Key features

- Clinical trial management
- Online and offline functionality
- Data access
- Study information management
- Mobile accessibility

## Recent user reviews (1 of 1)

All indexed reviews: https://appshunter.io/ios/app/ecaselinkme/id1524781385/reviews.md

### 1/5 — Needs to be cleaned up.

*2024-05-15*

I am using as a volunteer so should be simple sign in, click, date, and enter. Not so, especially now. I get a permanent update memo line on data screen. I updated months ago, nothing new since but line still there. I have to rotate phone to be able to get around line to input data. Dropped down calendar goes into line so have to rotate again and after dating rotate again to be able to click enter.

## Frequently asked questions about eCaseLinkMe

### What is eCaseLinkMe?

eCaseLinkMe is a free mobile application designed to help users manage their clinical trial information. It allows for both online and offline access to study-related data.

### Is eCaseLinkMe available on Android?

The current data indicates that eCaseLinkMe is available for iPhone and iPad. It is not specified if an Android version is available.

### How often is eCaseLinkMe updated?

The app was last updated on February 14, 2024, with version 1.17. This suggests a relatively active update schedule for maintenance and improvements.

### What devices support eCaseLinkMe?

eCaseLinkMe supports iPhone and iPad devices. It is designed for mobile use on these platforms.

### Does eCaseLinkMe have ads?

No, eCaseLinkMe does not contain advertisements. The app is free to use and does not display any ads.

### What is the age rating for eCaseLinkMe?

eCaseLinkMe has an age rating of 4+. This indicates it is suitable for a wide range of users, including children, for general use.

### What is the user rating for eCaseLinkMe?

eCaseLinkMe has a rating of 1.0 stars based on 1 rating. This low rating suggests potential issues that users have encountered.

### Can eCaseLinkMe be used without an internet connection?

Yes, eCaseLinkMe supports both online and offline usage. It utilizes your device's local storage for offline access to information.

## Version history (last 5 releases)

### 1.17 — 2024-02-14

Local Notifications Enabled

### 1.16 — 2023-08-11

Biometric login link is added

### 1.15 — 2023-08-07

LocalNotification and Link to App Update

### 1.14 — 2023-07-28

Update to Local Notification

### 1.13 — 2023-07-19

Local notification with clearing

## More apps by Signant Health Oy

- [TrialMax App](https://appshunter.io/ios/app/trialmax-app/id1002332076)
- [SmartSignals® eCOA](https://appshunter.io/ios/app/smartsignals-ecoa/id1602206850)
- [SmartSignals Telemedicine](https://appshunter.io/ios/app/smartsignals-telemedicine/id1614905124)
- [eCaseLinkMe MultiLingual](https://appshunter.io/ios/app/ecaselinkme-multilingual/id1617032750)
- [SmartSignals MyTrial](https://appshunter.io/ios/app/smartsignals-mytrial/id6478879469)

All apps by Signant Health Oy: https://appshunter.io/developer/885378600

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*